Signaling Pathways
-
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met inhibitor,non-ATP-competitive
-
A8326 AZD-54382 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK1/2/9 inhibitor
-
A8327 VerteporfinTarget: YAPSummary: Photosensitizer used in photodynamic therapy
-
A8328 LDK378Target: ALKSummary: Potent ALK inhibitor
-
A8329 R42810 CitationSummary: Selective Axl inhibitor
-
A8331 Bleomycin Sulfate1 CitationSummary: Chemotherapy agent, induces DNA strand break
-
A8332 R788 disodiumTarget: SykSummary: Syk inhibitor,ATP competitive and potent
-
A8333 Canagliflozin1 CitationTarget: SGLTSummary: SGLT2 inhibitor,potent and selective
-
A8335 Palbociclib (PD0332991) Isethionate1 CitationTarget: Cyclin-Dependent KinasesSummary: CDK4/6 inhibitor,highly selective
-
A8336 KU-600192 CitationTarget: ATM/ATRSummary: ATM kinase inhibitor,potent and selective